Sullivan & Worcester has advised PolyPid Ltd. in the transaction.PolyPid Ltd., a late-stage biopharma company listed on Nasdaq, has announced a warrant inducement transaction valued at…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
